课题基金 / 基金详情

Image-Guided Molecular Optical Spectroscopy for Tumor-Targeted Prostate Cancer Interventions

Image-Guided Molecular Optical Spectroscopy for Tumor-Targeted Prostate Cancer Interventions
用于肿瘤靶向前列腺癌干预的图像引导分子光谱
批准号:
523532-2018
负责人:
Kadoury, Samuel
金额:
$11.49万
依托单位国家:
加拿大
项目类别:
Collaborative Health Research Projects
财政年份:
2019
资助国家:
加拿大
项目状态:
已结题
起止时间:
2019-01-01 至 2020-12-31

项目摘要

项目成果

Kadoury, Samuel的其他基金

相似基金

相关文献

中文摘要
翻译
由于结构和表型的异质性,确定前列腺癌的位置、范围和分级以进行诊断和治疗仍然具有挑战性。在盲系统超声引导活检的情况下,这导致超过30%的假阴性率,而对于肿瘤靶向(局灶性)治疗,如近距离放疗,其成功取决于MRI癌症靶点的精确定位,以提供肿瘤的大致位置,但缺乏治疗位置的分子信息,没有准确的肿瘤分级,并可能导致毒性平衡不良。因此,没有现有的医疗技术能够在治疗过程中及时确认肿瘤的位置/分级。我们的目标是开发一种结合实时分子组织表征和光学拉曼光谱(RS)仪器的图像引导系统,用于肿瘤靶向前列腺癌干预,改善肿瘤定位和表征。具体来说,我们将使用实时导航平台技术开发和进行首次人体研究,允许在生物活检过程中高精度和肿瘤特异性采集样本。我们将在3年内完成四个研究目标,以确保将该技术转化为我们的合作伙伴Elekta和飞利浦加拿大公司的技术:(1)开发用于组织表征的光纤RS针装置,以指导前列腺干预;(2)从光谱RS特征中训练监督机器学习算法来推断生物特性;(3)实现实时RS组织分类和针迹跟踪的集成图像引导平台,识别具有前列腺运动补偿的MRI目标;(4)对MRI可见的局部PCa患者进行HDR近距离治疗的临床试点研究。最终,我们将拥有一种高端技术,用于前列腺干预的临床测试,用于实际的分子鉴定和癌症检测。
英文摘要
Confirming the location, extent, and grade of prostate cancer for diagnostic and therapeuticpurposes remains challenging due to the architectural and phenotypic heterogeneity. In thecase of blind systematic ultrasound-guided biopsies, this leads to more than 30% of falsenegative rates, while for tumor-targeted (focal) therapies such as brachytherapy, theirsuccess hinge on precise mapping of MRI cancer targets to provide the gross tumor location,but lack molecular information at the treatment location, without accurate grading of the tumorand can lead to a poor balance of toxicities. Therefore, there is no existing medicaltechnologies addressing the timely confirmation of tumor location/grade during therapy. Ourobjective is to develop an image-guidance system integrating real-time molecular tissuecharacterization with an optical Raman spectroscopy (RS) instrument for tumor-targetedprostate cancer interventions, improving tumor localization and characterization. Specifically,we will develop and conduct first in-human studies using a real-time navigation platformtechnology allowing for high-precision and tumor-specific harvesting of samples during biopsyprocedures. Four research aims will be completed to insure in-human translation of thetechnology into to our partners Elekta and Philips Canada within 3 years: (1) Develop a fiberoptics RS needle device for tissue characterization to guide prostate interventions; (2) Trainsupervised machine-learning algorithms from spectral RS signatures to infer biologicalproperties; (3) Implement an integrated image-guidance platform with real-time RS tissueclassification and needle tracking to identified MRI targets with prostate motion compensation;(4) Conduct a pilot clinical study patients with localized PCa visible on MRI and who willundergo HDR brachytherapy. Ultimately, we will have a high-end technique clinically tested inprostate interventions for practical molecular identification and cancer detection.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Intelligent Image Guided Interventions
  • 批准号:
    CRC-2017-00281
  • 项目类别:
    Canada Research Chairs
  • 资助金额:
    $3.64万
  • 财政年份:
    2022
  • 负责人:
    Kadoury, Samuel
  • 依托单位:
Prediction of Immunotherapy Response with Geometric Deep Learning in Medical Imaging
  • 批准号:
    RGPIN-2020-06558
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $3.5万
  • 财政年份:
    2022
  • 负责人:
    Kadoury, Samuel
  • 依托单位:
Prediction of Immunotherapy Response with Geometric Deep Learning in Medical Imaging
  • 批准号:
    RGPIN-2020-06558
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $3.5万
  • 财政年份:
    2021
  • 负责人:
    Kadoury, Samuel
  • 依托单位:
Intelligent Image Guided Interventions
  • 批准号:
    CRC-2017-00281
  • 项目类别:
    Canada Research Chairs
  • 资助金额:
    $7.29万
  • 财政年份:
    2021
  • 负责人:
    Kadoury, Samuel
  • 依托单位:
海外基金